IDUS in CBD Stone Recurrence High Risk Patients

Launched by SHANGHAI MUNICIPAL HOSPITAL OF TRADITIONAL CHINESE MEDICINE · Feb 16, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a way to help prevent the recurrence of stones in the common bile duct (CBD) in patients who are at high risk for developing them again after treatment. The researchers want to see if using a special imaging technique called Intraductal Ultrasound (IDUS) during an endoscopic procedure (a type of surgery done through the mouth) can help doctors find and treat these stones more effectively compared to the standard approach without IDUS.

To be eligible for this trial, participants should have a clinical diagnosis of CBD stones and meet certain criteria, such as having a larger duct or multiple stones. Patients in the study will be divided into two groups: one group will receive the IDUS treatment while the other will not. Throughout the study, the medical team will monitor various health aspects, including recovery details, any complications like pain, and whether the stones come back. This trial is currently looking for patients aged 65 and older, and both men and women can participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1.Clinical diagnosis of common bile duct stones 2.At least one of the following, diameter of CBD\>1.5cm, or number of calculi\>2, or lithotripsy during ercp
• Exclusion Criteria:
• • 1. Clinical diagnosis of liver or biliary malignant tumor. 2. Clinical diagnosis of duodenal malignant tumor 3. Failure or unexpected termination of ERCP 4. Surgery history of gallbladder or bile duct.